Literature DB >> 19997940

Development of renal and iliac aneurysms in a child with generalized infantile myofibromatosis.

Benoit Brasseur1, Christophe F Chantrain, Nathalie Godefroid, Thierry Sluysmans, Christine Anslot, Renaud Menten, Philippe Clapuyt, Sophie Dupont, Christiane Vermylen, Bénédicte Brichard.   

Abstract

Infantile myofibromatosis is a rare disorder characterized by the formation of tumors in the skin, soft tissues, bone, and viscera. We report the case of a 3-week-old girl who presented with severe hypertension due to generalized infantile myofibromatosis including renal involvement. The infant was treated by chemotherapy and showed progressive regression of the tumors. However, her evolution was marked by the development of aneurismal dilations of the renal and iliac arteries as observed in fibromuscular dysplasia. We discuss the possibility of a link between these two mesenchymal disorders.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19997940     DOI： 10.1007/s00467-009-1393-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


  10 in total

1.  Solitary renal myofibromatosis: an unusual cause of infantile hypertension.

Authors:  A B Kasaragod; M S Lucia; G M Lum; S Caldwell; L Stork; K R Stenmark
Journal:  Pediatrics       Date:  1999-05       Impact factor: 7.124

Review 2.  Fibromuscular dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

Review 3.  Autosomal dominant inheritance of infantile myofibromatosis.

Authors:  Dina J Zand; Dale Huff; David Everman; Karen Russell; Sulagna Saitta; Donna McDonald-McGinn; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2004-04-30       Impact factor: 2.802

Review 4.  Multivisceral fibromuscular dysplasia in childhood: case report and review of the literature.

Authors:  W Sandmann; K M Schulte
Journal:  Ann Vasc Surg       Date:  2000-09       Impact factor: 1.466

5.  A case of congenital multiple myofibromatosis developing in an infant.

Authors:  B J Schrodt; J P Callen
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

6.  Thromboembolic pulmonary hypertension due to disseminated fibromuscular dysplasia.

Authors:  H Fukuhara; H Kitayama; T Yokoyama; H Shirotani
Journal:  Pediatr Cardiol       Date:  1996 Sep-Oct       Impact factor: 1.655

7.  Multifocal infantile myofibromatosis and generalized fibromuscular dysplasia in a child: evidence for a common pathologic process?

Authors:  Corrina Wright; Martin T Corbally; Roisin Hayes; Michael B McDermott
Journal:  Pediatr Dev Pathol       Date:  2004 Jul-Aug

8.  Congenital generalized fibromatosis with visceral involvement. A case report.

Authors:  V L Roggli; H S Kim; E Hawkins
Journal:  Cancer       Date:  1980-03-01       Impact factor: 6.860

Review 9.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

10.  Congenital generalized myofibromatosis: a disseminated angiocentric myofibromatosis.

Authors:  C M Coffin; K A Neilson; S Ingels; R Frank-Gerszberg; L P Dehner
Journal:  Pediatr Pathol Lab Med       Date:  1995 Jul-Aug
  10 in total
  5 in total

1.  Somatic PDGFRB Activating Variants in Fusiform Cerebral Aneurysms.

Authors:  Yigit Karasozen; Joshua W Osbun; Carolina Angelica Parada; Tina Busald; Philip Tatman; Luis F Gonzalez-Cuyar; Christopher J Hale; Diana Alcantara; Mark O'Driscoll; William B Dobyns; Mitzi Murray; Louis J Kim; Peter Byers; Michael O Dorschner; Manuel Ferreira
Journal:  Am J Hum Genet       Date:  2019-04-25       Impact factor: 11.025

Review 2.  PDGF receptor mutations in human diseases.

Authors:  Emilie Guérit; Florence Arts; Guillaume Dachy; Boutaina Boulouadnine; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

Review 3.  Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.

Authors:  Alexandre Persu; Piotr Dobrowolski; Heather L Gornik; Jeffrey W Olin; David Adlam; Michel Azizi; Pierre Boutouyrie; Rosa Maria Bruno; Marion Boulanger; Jean-Baptiste Demoulin; Santhi K Ganesh; Tomasz J Guzik; Magdalena Januszewicz; Jason C Kovacic; Mariusz Kruk; Peter de Leeuw; Bart L Loeys; Marco Pappaccogli; Melanie H A M Perik; Emmanuel Touzé; Patricia Van der Niepen; Daan J L Van Twist; Ewa Warchoł-Celińska; Aleksander Prejbisz; Andrzej Januszewicz
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

4.  Kidney transplantation in infantile myofibromatosis and fibromuscular dysplasia: a case report.

Authors:  Julie Frezin; Fabio Fusaro; Raymond Reding; Nathalie Godefroid
Journal:  J Med Case Rep       Date:  2015-11-25

5.  Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.

Authors:  Simone Hettmer; Guillaume Dachy; Guido Seitz; Abbas Agaimy; Catriona Duncan; Marjolijn Jongmans; Steffen Hirsch; Iris Kventsel; Uwe Kordes; Ronald R de Krijger; Markus Metzler; Orli Michaeli; Karolina Nemes; Anna Poluha; Tim Ripperger; Alexandra Russo; Stephanie Smetsers; Monika Sparber-Sauer; Eveline Stutz; Franck Bourdeaut; Christian P Kratz; Jean-Baptiste Demoulin
Journal:  Fam Cancer       Date:  2020-09-05       Impact factor: 2.375
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.